Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03121287
Other study ID # UMCC 2015.006
Secondary ID HUM00097162
Status Completed
Phase
First received
Last updated
Start date September 23, 2015
Est. completion date January 2019

Study information

Verified date August 2019
Source University of Michigan Rogel Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate if cardiac MRI, blood biomarkers, and lung CT scans can detect early changes to the associated with radiation therapy in patients receiving radiation treatment for thoracic cancer.


Description:

This study seeks to investigate the utility of novel imaging biomarkers, namely whole lung volumetric CT scans and cardiac MRI, to non-invasively identify early pathologic changes in pulmonary and cardiac function resulting from thoracic radiation. The ability to identify these changes during the course of treatment offers a powerful tool to optimize radiation dose distributions within uninvolved normal tissue by adapting treatment to the individual patient response. In addition it may lead to other therapeutic interventions designed to reduce long term cardiopulmonary toxicity.

The cardiac MRI will be performed using Aminophylline, Gadopentetate Dimeglumine and Regadenoson. These are not FDA approved for this purpose, but are being used off label and are IND exempt. Additionally, patients will be consented with an optional choice to retain research blood samples for 15 years after the completion of the study. This will allow cutting edge analysis for biomarkers that may be discovered in the future.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date January 2019
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients receiving once daily fractionated intrathoracic radiation therapy for:

- Stage IIA-IIIB non-small cell lung cancer

- Limited stage small cell lung cancer

- Stage I-III esophageal cancer (neoadjuvant or definitive)

- Patients must be 18 years of age or older

- Must not be claustrophobic

- Must have adequate kidney function

Exclusion Criteria:

- Patients with small cell lung cancer receiving twice daily (b.i.d.) radiation

- Patients with esophageal cancer receiving trastuzamab

- Pregnancy or lactation

- Claustrophobia

- Inability to lie flat for 60-90 minutes

- Renal dysfunction with eGFR <60 mL/min/1.73 m2

- Allergy to gadolinium containing contrast media

- Implanted devices, metallic hazards or other conditions presenting a contraindication to 3Tesla cardiac MRI

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Imaging Biomarkers
Whole lung volumetric CT scans
Pulmonary
Pulmonary Function Tests & 6 minute hall walk
Imaging
Cardiac MRI
Specimen Collection
Blood draw

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan Rogel Cancer Center Department of Health and Human Services

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Radiation Induced Change from Baseline in Imaging To determine if early imaging-based changes are associated with radiation induced pulmonary and cardiac injury at 6- and 12-months 6 month and 1 year post treatment
Primary Change from Baseline in Lung Function To characterize longitudinal changes in lung function using a voxel-wise image analysis technique of whole-lung CT scans in patients undergoing intrathoracic radiation therapy. 1 Year post treatment
Secondary Change from Baseline in Myocardial Tissue To assess longitudinal changes in myocardial tissue and coronary vasculature physiology, using cardiac MR in patients undergoing intrathoracic radiation therapy. 1 Year post treatment
Secondary Change from Baseline in Myocardial Tissue To assess longitudinal changes in myocardial tissue and coronary vasculature physiology, including microvascular dysfunction, using cardiac MR in patients undergoing intrathoracic radiation therapy. 1 Year post treatment
Secondary Change from Baseline in Myocardial Tissue To assess longitudinal changes in myocardial tissue and coronary vasculature physiology, including diffuse fibrosis, using cardiac MR in patients undergoing intrathoracic radiation therapy. 1 Year post treatment
Secondary Radiation Predictors from Baseline in Cardiopulmonary Changes To explore radiation dosimetric predictors of CT- and MR-detectible cardiopulmonary changes. 1 Year post treatment
See also
  Status Clinical Trial Phase
Recruiting NCT04837950 - Changes in Pleural Cavity Volume and Surgical Exposure N/A
Completed NCT04553471 - Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers N/A
Recruiting NCT05053230 - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer N/A
Completed NCT04570722 - Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) N/A
Completed NCT05459311 - Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)
Completed NCT01833637 - Electronic Patient Reported Symptom Assessment N/A
Completed NCT03676426 - Comparison of a Web-based Advance Directive to a Standard Advance Directive N/A
Completed NCT03658083 - Exploring Robotic-assisted Thoracic Surgery for Lung Cancer
Recruiting NCT05063396 - OFA in Thoracic Surgery N/A
Recruiting NCT03804307 - Short Course Radiation Therapy in Palliative Treatment of Thoracic Cancer N/A
Enrolling by invitation NCT05629065 - Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) N/A
Recruiting NCT04749212 - Perioperative Troponin I and NT Pro-BNP in Lung Resection
Recruiting NCT05351268 - 3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors N/A
Recruiting NCT05349552 - Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
Recruiting NCT05502263 - Interest of CPET to Predict Mortality and Complications of Lung Resection Candidates
Recruiting NCT05549414 - Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System N/A
Recruiting NCT06342284 - Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Recruiting NCT04799561 - Teleprehabilitation for Surgical Cancer Patients N/A
Completed NCT05143541 - Use of a New Stapling Device in General Thoracic Surgery
Active, not recruiting NCT04686500 - VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors N/A